Growth Metrics

Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2025)

Historic Amortization - Intangibles for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • Axsome Therapeutics' Amortization - Intangibles rose 6.23% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 26.6%. This contributed to the annual value of $6.4 million for FY2024, which is 26.67% up from last year.
  • Axsome Therapeutics' Amortization - Intangibles amounted to $1.6 million in Q3 2025, which was up 6.23% from $1.6 million recorded in Q2 2025.
  • Axsome Therapeutics' Amortization - Intangibles' 5-year high stood at $1.6 million during Q3 2022, with a 5-year trough of $926000.0 in Q2 2022.
  • In the last 4 years, Axsome Therapeutics' Amortization - Intangibles had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • Per our database at Business Quant, Axsome Therapeutics' Amortization - Intangibles surged by 7159.83% in 2023 and then tumbled by 106.99% in 2025.
  • Quarter analysis of 4 years shows Axsome Therapeutics' Amortization - Intangibles stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.6 million for Q2 2025, and $1.6 million during Q1 2025.